Insta
Ahmedabad Based Zydus Cadila Seeks DCGI Nod For Phase-3 Clinical Trials Of Its COVID-19 Vaccine With 30,000 Volunteers
Swarajya Staff
Dec 25, 2020, 09:32 AM | Updated 09:32 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
In a positive development, Ahmedabad based pharmaceutical major Zydus Cadila has reached out to the Drugs Controller General of India (DCGI), seeking the nod to begin Phase-III clinical trials of its COVID-19 vaccine candidate called 'ZyCoV-D', reports Times of India.
The plasmid DNA vaccine candidate has been found to be safe, well-tolerated and immunogenic in the Phase-I and Phase-II clinical trials. Now, the company is looking to conduct a massive Phase-III clinical trial of the vaccine with around 30,000 volunteers.
In the Phase-II clinical trial, the company tested the vaccine on over 1,000 healthy adult volunteers as a part of the adaptive Phase-I and Phase-II dose-escalation, multi-centric, randomised and double-blind placebo-controlled study.
"We are optimistic of Phase-III clinical trial outcomes as well and that we would be able to start the production of the Novel Vaccine on its successful completion," Zydus' chairman Pankaj R Patel said.
It should be noted that the company has also claimed that the DNA vaccine platform established by it can also be used to modify the vaccine in a couple of weeks in case the virus mutates.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.